MA38912A1 - Formulations pharmaceutiques effervescentes pauvres en sodium - Google Patents
Formulations pharmaceutiques effervescentes pauvres en sodiumInfo
- Publication number
- MA38912A1 MA38912A1 MA38912A MA38912A MA38912A1 MA 38912 A1 MA38912 A1 MA 38912A1 MA 38912 A MA38912 A MA 38912A MA 38912 A MA38912 A MA 38912A MA 38912 A1 MA38912 A1 MA 38912A1
- Authority
- MA
- Morocco
- Prior art keywords
- effervescent
- sodium
- pharmaceutical formulations
- effervescent pharmaceutical
- organic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Diabetes (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne une composition de granulé ou de poudre ou de comprimé effervescente stable, exempte d'excipients qui peuvent réagir avec un constituant d'acide organique effervescent, comprenant : une quantité efficace d'un médicament antidiabétique, un constituant d'acide organique effervescent, un constituant de base effervescent; des tampons, pour moduler un acide gastrique après ingestion, essentiellement exempts de sodium; ladite composition étant entièrement solubilisée en 5 minutes sans remuer dans 3 à 8 onces liquides d'eau entre 5 et 20 °c.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361880875P | 2013-09-21 | 2013-09-21 | |
PCT/IB2014/000826 WO2015040460A1 (fr) | 2013-09-21 | 2014-03-01 | Formulations pharmaceutiques effervescentes pauvres en sodium |
Publications (1)
Publication Number | Publication Date |
---|---|
MA38912A1 true MA38912A1 (fr) | 2017-03-31 |
Family
ID=51136510
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA38912A MA38912A1 (fr) | 2013-09-21 | 2014-03-01 | Formulations pharmaceutiques effervescentes pauvres en sodium |
Country Status (10)
Country | Link |
---|---|
US (1) | US20160220481A1 (fr) |
EP (1) | EP3046549A1 (fr) |
JP (1) | JP2016531161A (fr) |
KR (1) | KR20160065074A (fr) |
AU (1) | AU2014322810A1 (fr) |
CA (1) | CA2922977A1 (fr) |
IL (1) | IL244384A0 (fr) |
MA (1) | MA38912A1 (fr) |
TW (1) | TW201545775A (fr) |
WO (1) | WO2015040460A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2017060861A2 (fr) * | 2015-10-07 | 2017-04-13 | Steerlife India Private Limited | Compositions de comprimés à délitation rapide d'inhibiteurs de dpp-iv à faible teneur en minéraux |
EP3799864B1 (fr) | 2019-10-02 | 2023-03-01 | Intas Pharmaceuticals Limited | Compositions pharmaceutiques solides effervescentes essentiellement exemptes de sodium |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007038979A1 (fr) * | 2005-09-22 | 2007-04-12 | Swissco Development Ag | Composition effervescente de metformine et comprimés et granules fabriqués à partir de cette composition |
CN101234105A (zh) * | 2008-01-09 | 2008-08-06 | 北京润德康医药技术有限公司 | 一种含有二甲双胍和维格列汀的药用组合物及其制备方法 |
EP2809311A1 (fr) * | 2012-01-31 | 2014-12-10 | Mahmut Bilgic | Formulations de comprimés effervescents contenant la combinaison voglibose et metformine |
-
2014
- 2014-03-01 JP JP2016543468A patent/JP2016531161A/ja active Pending
- 2014-03-01 CA CA2922977A patent/CA2922977A1/fr not_active Abandoned
- 2014-03-01 EP EP14736431.9A patent/EP3046549A1/fr not_active Withdrawn
- 2014-03-01 US US15/021,214 patent/US20160220481A1/en not_active Abandoned
- 2014-03-01 MA MA38912A patent/MA38912A1/fr unknown
- 2014-03-01 WO PCT/IB2014/000826 patent/WO2015040460A1/fr active Application Filing
- 2014-03-01 AU AU2014322810A patent/AU2014322810A1/en not_active Abandoned
- 2014-03-01 KR KR1020167003690A patent/KR20160065074A/ko not_active Application Discontinuation
- 2014-09-19 TW TW103132382A patent/TW201545775A/zh unknown
-
2016
- 2016-03-02 IL IL244384A patent/IL244384A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3046549A1 (fr) | 2016-07-27 |
JP2016531161A (ja) | 2016-10-06 |
US20160220481A1 (en) | 2016-08-04 |
WO2015040460A1 (fr) | 2015-03-26 |
AU2014322810A1 (en) | 2016-02-11 |
IL244384A0 (en) | 2016-04-21 |
TW201545775A (zh) | 2015-12-16 |
KR20160065074A (ko) | 2016-06-08 |
CA2922977A1 (fr) | 2015-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA48763A (fr) | Composition pharmaceutique comprenant des constructions d'anticorps bispécifiques pour un stockage et une administration améliorés | |
MA41265B1 (fr) | Compositions pour administration de médicaments iléo-jéjunal. | |
PH12017500844B1 (en) | Stable protein solution formulation containing high concentration of an anti-vegf antibody | |
MA32027B1 (fr) | Preparation de capsules | |
HRP20230748T1 (hr) | Pripravci agonista gip/glp1 | |
MA42561A (fr) | Procédés de formulation de compositions de conjugués anticorps-médicament | |
MA39359A1 (fr) | Composés d'isoindolinone utilisés comme modulateurs de gpr119 pour le traitement du diabète, de l'obésité et de troubles associés | |
MX2016008977A (es) | Formulaciones farmaceuticas de insulina aspart estabilizadas. | |
FR3058059B1 (fr) | Composition pharmaceutique comprenant le beta-elemene, le lupeol et le 2-hydroxycinnamaldehyde et/ou le 2'-benzoyloxycinnalmaldehyde et/ou le beta-sitosterol et/ou la curcumine. | |
MX2022001146A (es) | Formulaciones de anticuerpos anti-pvrig y sus usos. | |
PH12014502191A1 (en) | Capsule disintegrable in large-intestine-specific manner | |
MA43876A (fr) | Compositions pharmaceutiques et leur utilisations contre les maladies de surcharge lysosomale | |
BR112012030641A2 (pt) | métodos e composições para terapia farmacêutica oral | |
MA49116A (fr) | Compositions pharmaceutiques contenant de l'insuline | |
EA201692106A1 (ru) | Пищевые продукты, системы, способы и наборы для замены электролитов | |
FR2984750B1 (fr) | Nouvelles compositions pharmaceutiques comprenant un anticorps liant le recepteur humain de l'hormone anti-mullerienne de type ii | |
MA38912A1 (fr) | Formulations pharmaceutiques effervescentes pauvres en sodium | |
MA49947A (fr) | Compositions pharmaceutiques contenant des anticorps anti-bêta-amyloïdes | |
FR3073142B1 (fr) | Formulation cosmetique | |
EA201691660A1 (ru) | Применение обратно-мицеллярных систем для осуществления доставки хелатирующих агентов радионуклидов и металлов | |
ZA201404068B (en) | The use of silver(i) complexes as active pharmaceutical ingredients (api's) iincluding anticancer agents | |
MX2017015202A (es) | Formulaciones liquidas de celecoxib para administracion oral. | |
MA41102A (fr) | Compositions contenant de la curcumine à biodisponibilité améliorée | |
EA201791458A1 (ru) | Фармацевтическая композиция для лечения заболеваний желудочно-кишечного тракта | |
MA38871A1 (fr) | Complexe lubrifiant pour la bouche |